Jose Lutzky on Proactively Monitoring Patients Receiving Immunotherapy Treatments

Friday, April 07, 2017

Jose Lutzky, MD, from Mount Sinai Medical Center, discusses the best practices for monitoring patients on immunotherapy.

With treatments that are potentially very toxic, it is important to develop a plan for following up with the patients. Every patient is different and some will need closer monitoring than others. Nurses shouldn’t rely on the patient to reach out to them, either. For treatments that could possibly result in these kinds of adverse events, it is better to take a more proactive approach to patient monitoring.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.